| Literature DB >> 32401749 |
Zhenling Yang1, Qingfeng Yin2, Xiaodong Li3,4.
Abstract
BACKGROUND This study discussed potential influences of UDP glucuronosyltransferase family 2 member B7 (UGT2B7) rs7439366 and rs12233719 polymorphisms on fentanyl sensitivity among Chinese gynecologic patients. MATERIAL AND METHODS UGT2B7 polymorphisms were genotyped by polymerase chain reaction (PCR) and direct sequencing. Before surgery, baseline latency to pain perception (PPLpre) and pain perception latency of the dominant hand (PPLpost) at 3 minutes after injecting fentanyl were measured by cold pressor-induced pain test. Perioperative fentanyl adoption referred to the total of fentanyl administration during and after operation. Intensity of spontaneous pain was appraised adopting 100-mm visual analog scale (VAS). Factorial analysis was performed by Mann-Whitney U test and Kruskal-Wallis H test. RESULTS Significant differences of PPLpost (CC/CT/TT, P=0.038) and preoperative analgesic effect (CC/CT/TT, P=0.028) were discovered between the rs7439366 genotypes. PPLpost was significantly different between the CT and TT groups (P=0.009) and the CC+CT and TT groups (P=0.026). Preoperative analgesic effect was significantly different between the CT and TT groups (P=0.007) and the CC+CT and TT groups (P=0.009). All of the clinical features studied had no close association with rs12233719 SNP. CONCLUSIONS Gynecologic patients with rs7439366 TT genotype had significantly lower fentanyl sensitivity than the other 2 genotype carriers.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32401749 PMCID: PMC7245057 DOI: 10.12659/MSM.924153
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Basic and clinical features of patients.
| Features | Mean±SD | Range |
|---|---|---|
| Age (years) | 34.95±8.02 | 20–50 |
| Body weight (kg) | 53.70±8.88 | 30–80 |
| PPLpre (s) | 15.89±9.84 | 1–93 |
| PPLpost (s) | 31.95±16.02 | 4–103 |
| Preoperative analgesic effect (s) | 16.06±11.79 | −34–57 |
| Intraoperative fentanyl use (μg/kg) | 4.01±2.52 | 0–13.6 |
| 24h postoperative fentanyl use (μg/kg) | 2.61±2.59 | 0–13.8 |
| Perioperative fentanyl use (μg/kg) | 6.62±4.12 | 0.2–25.2 |
| VAS score at 3 hours (mm) | 28.83±12.49 | 0–90 |
| VAS score at 24 hours (mm) | 26.17±11.86 | 0–84 |
Clinical features among different genotypes.
| SNP | N (%) | PPLpre (s) | PPLpost (s) | Preoperative analgesic effect (s) | Intraoperative fentanyl use (μg/kg) |
|---|---|---|---|---|---|
| rs7439366 | |||||
| CC | 111 (37.88) | 15.41±8.40 | 31.45±17.58 | 16.05±11.96 | 4.21±2.56 |
| CT | 148 (50.51) | 16.55±11.08 | 33.52±15.69 | 16.97±12.19 | 3.88±2.57 |
| TT | 34 (11.60) | 14.59±8.42 | 26.76±10.31 | 12.18±8.46 | 3.96±2.24 |
| | 0.145 | ||||
| rs12233719 | |||||
| GG | 208 (70.99) | 16.25±10.28 | 32.17±16.11 | 15.92±11.91 | 3.99±2.63 |
| GT | 76 (25.94) | 14.83±8.89 | 31.95±16.24 | 17.12±11.33 | 4.02±2.15 |
| TT | 9 (3.07) | 16.44±6.89 | 26.89±12.68 | 10.44±12.43 | 4.48±3.17 |
| | 0.256 | ||||
| rs7439366 | |||||
| CC | 111 (37.88) | 2.74±2.66 | 6.95±4.35 | 28.05±12.13 | 25.53±11.85 |
| CT | 148 (50.51) | 2.67±2.72 | 6.55±4.13 | 29.77±13.15 | 27.00±11.97 |
| TT | 34 (11.60) | 1.87±1.50 | 5.83±3.12 | 27.29±10.54 | 25.53±11.48 |
| | 0.145 | ||||
| rs12233719 | |||||
| GG | 208 (70.99) | 2.58±2.55 | 6.57±4.26 | 28.43±12.91 | 25.85±12.29 |
| GT | 76 (25.94) | 2.67±2.81 | 6.69±3.73 | 30.33±11.64 | 27.51±10.89 |
| TT | 9 (3.07) | 2.66±1.59 | 7.13±4.29 | 25.44±8.68 | 22.33±9.08 |
| | 0.256 | ||||
Association analysis between clinical features and rs7439366.
| Features | CC/CT/TT (Kruskal-Wallis) | CC/CT (Mann-Whitney) | CC/TT (Mann-Whitney) | CT/TT (Mann-Whitney) | CC+CT/TT (Mann-Whitney) | CC/CT+TT (Mann-Whitney) |
|---|---|---|---|---|---|---|
| PPLpre (s) | 0.599 | 0.565 | 0.547 | 0.345 | 0.401 | 0.761 |
| PPLpost (s) | 0.038 | 0.224 | 0.146 | 0.009 | 0.026 | 0.557 |
| Preoperative analgesic effect (s) | 0.028 | 0.563 | 0.028 | 0.007 | 0.009 | 0.859 |
| Intraoperative fentanyl use (μg/kg) | 0.422 | 0.207 | 0.529 | 0.634 | 0.995 | 0.207 |
| 24 h postoperative fentanyl use (μg/kg) | 0.302 | 0.480 | 0.109 | 0.297 | 0.173 | 0.277 |
| Perioperative fentanyl use (μg/kg) | 0.549 | 0.650 | 0.254 | 0.439 | 0.323 | 0.464 |
| VAS score at 24 h (mm) | 0.491 | 0.313 | 0.785 | 0.377 | 0.514 | 0.440 |
P<0.05;
P<0.017 (significant level which was adjusted by Bonferroni method).